Allurion Technologies (ALUR) Expected to Announce Quarterly Earnings on Wednesday

Allurion Technologies (NYSE:ALUR) is anticipated to post its Q3 2025 results before the market opens on Wednesday, November 12th. Analysts expect the company to announce earnings of ($2.45) per share and revenue of $2.05 million for the quarter. Interested persons can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Wednesday, November 12, 2025 at 8:30 AM ET.

Allurion Technologies (NYSE:ALUR) last released its earnings results on Tuesday, August 19th. The company reported ($0.57) earnings per share for the quarter, beating the consensus estimate of ($0.65) by $0.08. The business had revenue of $3.38 million for the quarter, compared to the consensus estimate of $6.20 million. On average, analysts expect Allurion Technologies to post $-10 EPS for the current fiscal year and $-7 EPS for the next fiscal year.

Allurion Technologies Stock Performance

Shares of ALUR opened at $1.55 on Monday. The company has a market cap of $12.03 million, a price-to-earnings ratio of -0.12 and a beta of -0.46. The firm has a fifty day moving average of $2.02 and a 200-day moving average of $2.41. Allurion Technologies has a 1 year low of $1.52 and a 1 year high of $19.13.

Analysts Set New Price Targets

ALUR has been the subject of several research analyst reports. Wall Street Zen lowered Allurion Technologies from a “hold” rating to a “strong sell” rating in a report on Saturday, August 16th. Zacks Research raised Allurion Technologies to a “hold” rating in a research note on Tuesday, August 12th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Allurion Technologies in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Allurion Technologies presently has an average rating of “Hold” and an average target price of $9.25.

Institutional Trading of Allurion Technologies

An institutional investor recently raised its position in Allurion Technologies stock. XTX Topco Ltd boosted its holdings in shares of Allurion Technologies, Inc. (NYSE:ALUR) by 43.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,670 shares of the company’s stock after purchasing an additional 5,633 shares during the period. XTX Topco Ltd owned about 0.25% of Allurion Technologies worth $45,000 as of its most recent SEC filing. 21.39% of the stock is owned by institutional investors and hedge funds.

About Allurion Technologies

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.